Don’t send a generic resume — generate a resume and cover letter tailored to this exact role.
Waypoint Bio is looking for a highly-motivated Scientist/Senior Scientist in New York to innovate genetic engineering processes for cancer therapies. The position involves designing and testing novel T cell therapies using cutting-edge screening technologies, contributing to groundbreaking treatments for solid tumors.
The ideal candidate holds a Ph.D. and has extensive experience with genetic engineering tools and immune cell therapies. Join our collaborative team and make an impact in advancing cancer care.
Waypoint Bio a venture-backed biotech startup innovating in spatial and computational biology and their application to advancing cancer therapies. Our leading focus is the development of next generation cell therapies for solid tumors. Our proprietary platform overcomes a major obstacle — the tradeoff between fast but inaccurate in vitro experiments and more accurate but slow and expensive in vivo approaches — that holds back traditional cell therapy preclinical development. Combining spatial pooled screening, in silico engineering, and machine learning, we obtain both depth and breadth when screening cell therapy candidates: speed without compromising on in vivo accuracy. Our team is highly collaborative, interdisciplinary, and committed to developing breakthrough therapies to benefit patients’ lives.
We are seeking a highly-motivated, rigorous, and creative scientist who thrives in a fast-paced collaborative environment. In this position, you will design new screens for novel T cell therapies, manufacture those cell therapies, and work collaboratively to test their function in complex animal models. The ideal candidate will have deep expertise designing and using genetic engineering tools — such as lentivirus, AAVs, virus-like particles, or lipid nanoparticles — for both in vitro genetic editing and directly in animal models. This person will also have technical experience working with immune cells, and conceptual knowledge of pooled screening approaches. Our high-throughput screening platform creates a unique opportunity for inventive minds to design & test novel ideas for better-engineered cell therapies. We seek broadly knowledgeable and creative thinkers who bring together ideas from disparate areas of biology to make the most of this opportunity.
The role reports directly to our Chief Scientific Officer, David Phizicky.